The third International Drug Repurposing Conference, iDR26: Navigating the Future of Drug Repurposing, brought together the international drug repurposing community in Brussels on 12-13 May 2026. Co-organised by REMEDi4ALL and Beacon for Rare Diseases, the event provided a platform for researchers, clinicians, patient advocates, policy-makers, funders, regulators and industry representatives to explore how medicines repurposing can help accelerate access to treatments for patients with high unmet medical needs.
Under the theme “Navigating the future of drug repurposing”, discussions focused on a broad range of topics shaping the field, including rare diseases, artificial intelligence-driven drug discovery, policy and regulatory developments, funding pathways, and community-led success stories. Throughout the two-day programme, participants shared emerging research, practical experience and new opportunities for collaboration aimed at advancing patient-centred medicines repurposing.
Beyond the scientific programme, iDR26 reinforced the importance of collaboration across the entire repurposing ecosystem. The conference was designed to connect diverse stakeholders, encourage knowledge exchange and help address the challenges that still limit patient access to repurposed therapies.
As a partner in REMEDi4ALL, Teamit contributed to the conference through communications, stakeholder engagement and event management activities, working alongside project partners to maximise the event’s reach and create opportunities for meaningful exchange across the drug repurposing landscape.
iDR26 reflects the broader ambition of REMEDi4ALL to build a sustainable and connected drug repurposing ecosystem in Europe and beyond. By creating spaces where patients, researchers, funders and decision-makers can learn from one another, the conference series continues to strengthen collaboration and support the development of new pathways that could help bring repurposed medicines to those who need them most.
